Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
12.37
+1.08 (9.57%)
At close: Nov 9, 2026, 4:00 PM EST
12.42
+0.05 (0.40%)
Pre-market: Nov 10, 2026, 7:01 AM EST

Ginkgo Bioworks Holdings Revenue

Ginkgo Bioworks Holdings had revenue of $27.71M in the quarter ending September 30, 2026, a decrease of -5.68%. In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%. That makes Ginkgo Bioworks Holdings the 20,707th largest company in the world by revenue and 3,128th in the United States.

Revenue (ttm)
$170.16M
Revenue Growth
-25.06%
P/S Ratio
6.37
Revenue / Employee
$269,592
Employees
485
Market Cap
833.00M

Revenue Chart

Revenue by Segment

  • Cell Engineering 132.75M 78.0%
  • Biosecurity Service 37.41M 22.0%

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025170.16M-56.89M-25.06%
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ardelyx468.22M
Rigel Pharmaceuticals288.21M
Arbutus Biopharma181.72M
OmniAb40.21M
Lexicon Pharmaceuticals38.54M
Alumis7.40M
Revenue Rankings